ClinicalTrials.Veeva

Menu

Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions (Spray A)

Eurofarma logo

Eurofarma

Status

Completed

Conditions

Skin Lesions
Skin Lesion
Skin Care

Treatments

Device: Saline solution
Device: EF192A

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The investigational product constitutes a medical device that is freely accessible to consumers and, as such, must be safe under real or reasonably foreseeable conditions of use and its safety must be tested before being placed on the market. Therefore, this study was designed to evaluate the biocompatibility of the experimental product, as provided for in legislation.

Enrollment

88 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 18 and 70 years old.
  • Fitzpatrick phototype I to IV.
  • Presence of intact skin in the test region.
  • Agreement to comply with the study procedures and requirements and attend the institute on the days and times determined for the assessments.
  • Signature of the Informed Consent Form (ICF) before carrying out any study procedure.

Exclusion criteria

  • Presence of skin marks in the test region that interfere with the assessment of possible skin reactions (for example, pigmentation disorders, vascular malformations, scars, increased hairiness, large quantities of ephelides and nevus, sunburn).
  • Presence of active dermatosis (local or disseminated) that could interfere with the study results.

istory of atopy (atopic dermatitis, allergic rhinitis, allergic bronchitis, allergic conjunctivitis, etc.).

  • History of allergic reactions, irritation or intense sensations of discomfort to topical products such as, for example, cosmetics, health products or medicines.

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

88 participants in 2 patient groups

EF192A
Experimental group
Description:
EF192A will be distributed on a contact test filter paper disc, appropriately identified, in the letter of the alphabet corresponding to the experimental product.
Treatment:
Device: EF192A
Saline Solution
Sham Comparator group
Description:
Saline solution - The sterile saline solution (NaCl 0.9%) will be used as control in another contact test filter paper disc, appropriately identified, in the letter of the alphabet corresponding to the control.
Treatment:
Device: Saline solution

Trial contacts and locations

1

Loading...

Central trial contact

Luiza Terranova; Gleyce Lima

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems